Kent lake urges quanterix management to address key questions regarding its proposed transaction with akoya biosciences during today's earnings call

Rincon, puerto rico--(business wire)--kent lake pr llc (“kent lake”) is a holder of 7.47% of the outstanding common stock of quanterix corporation (“quanterix” or the “company”) (nasdaq: qtrx). kent lake has previously issued a public presentation detailing its opposition to the company's proposed transaction (the “transaction”) with akoya biosciences (“akoya”) (nasdaq: akya), and has also nominated three highly qualified, independent candidates for election to the company's board of directors.
AKYA Ratings Summary
AKYA Quant Ranking